Princess Margaret Hospital — Toronto

Public research footprint of Princess Margaret Hospital, compiled from the ClinicalTrials.gov public registry.

1,164

Registered studies

205

Active

Recruiting now

811

Completed

113

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia Arising From Previous… · Myelodysplastic Syndrome · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Recurrent Endometrial Clear Cell Adenocarcinoma

Recently updated registry entries

NCT05171647 — A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab… (Active Not Recruiting)
NCT05564390 — MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study… (Recruiting)
NCT05812807 — Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Princess Margaret Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.